Novo Nordisk has withdrawn its application to expand the label of Wegovy, its blockbuster weight loss medication, the company announced Aug. 7.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Novo Nordisk postpones Wegovy label expansion
